Glucocorticoids Oppose Thymocyte Negative Selection by Inhibiting Helios and Nur77

Area of Science:

• Immunology
• Molecular Biology
• Endocrinology

Background:

• Glucocorticoid (GC) signaling in thymocytes is crucial for shaping the T cell receptor (TCR) repertoire.
• GCs antagonize thymocyte negative selection, a critical process for immune tolerance.
• Nur77 and Helios are transcription factors upregulated by TCR signaling and implicated in negative selection.

Purpose of the Study:

• To investigate the role of Glucocorticoids (GCs) in regulating Nur77 and Helios expression in thymocytes.
• To determine the specific contributions of Nur77 and Helios to GC-mediated regulation of thymocyte negative selection.
• To elucidate the signaling threshold for thymocyte negative selection.

Main Methods:

• Quantitative analysis of Nur77 and Helios mRNA and protein levels in mouse thymocytes under various conditions.
• Gene deletion studies (Nur77 and Helios knockout mice) in the context of GC receptor signaling.
• Flow cytometry to assess thymocyte populations (CD4+, CD8+, TCRhi).

Main Results:

• GCs were found to inhibit Helios and, to a lesser extent, Nur77 upregulation in TCR-stimulated thymocytes.
• GC-mediated inhibition of Helios and Nur77 was indirect, involving an intermediary factor and requiring protein synthesis.
• Deletion of Helios fully reversed GC-induced negative selection, while Nur77 deletion partially reversed the loss of mature CD4+ thymocytes.

Conclusions:

• Nur77 and Helios are direct or indirect targets of GC signaling in thymocytes.
• Nur77 and Helios play distinct, nonredundant roles in setting the signaling threshold for thymocyte negative selection.
• GCs fine-tune the TCR repertoire by modulating the expression of key transcription factors involved in negative selection.